Authors: Oka, M Matsumoto, Y Sugiyama, S Tsuruta, N Matsushima, M

Citation: M. Oka et al., A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2 ',5 '-dioxospiro[chroman-4,4 '-imidazolidine]-2-carboxamide (Fidarestat): Its absolute configuration and interactions with the aldose reductase by X-ray crystallography, J MED CHEM, 43(12), 2000, pp. 2479-2483

Authors: Yatsunami, J Fukuno, Y Nagata, M Tsuruta, N Aoki, S Tominaga, M Kawashima, M Taniguchi, S Hayashi, S

Citation: J. Yatsunami et al., Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells, CANCER LETT, 147(1-2), 1999, pp. 17-24

Authors: Yatsunami, J Fukuno, Y Nagata, M Tominaga, M Aoki, S Tsuruta, N Kawashima, M Taniguchi, S Hayashi, S

Citation: J. Yatsunami et al., Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells, CLIN EXP M, 17(4), 1999, pp. 361-367

Authors: Yatsunami, J Tsuruta, N Fukuno, Y Kawashima, M Taniguchi, S Hayashi, S

Citation: J. Yatsunami et al., Inhibitory effects of roxithromycin on tumor angiogenesis, growth and metastasis of mouse B16 melanoma cells, CLIN EXP M, 17(2), 1999, pp. 119-124

Authors: Kakigami, T Tsuruta, N Tsukamoto, K Usui, T Ikami, T

Citation: T. Kakigami et al., A 3D-quantitative structure-activity relationship study of benzamide type serotonin 5-HT4 receptor agonists based on a comparative molecular field analysis model, and the design and synthesis of potent agonists, CHEM PHARM, 46(12), 1998, pp. 1881-1886